Antares Pharma Inc (ATRS.OQ)
ATRS.OQ on NASDAQ Stock Exchange Capital Market
3.14USD
25 Jun 2019
3.14USD
25 Jun 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$3.14
$3.14
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
240,435
240,435
52-wk High
$3.96
$3.96
52-wk Low
$2.46
$2.46
Revenue & Earnings Per Share
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
No consensus analysis data available.
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 32.13 | 32.55 | |
| P/E High - Last 5 Yrs. | -- | 40.21 | 48.11 | |
| P/E Low - Last 5 Yrs. | -- | 19.56 | 23.41 | |
| Beta | 0.28 | 0.79 | 0.87 | |
| Price to Sales (TTM) | 305.28 | 6.67 | 8.44 | |
| Price to Book (MRQ) | -- | 4.94 | 5.27 | |
| Price to Tangible Book (MRQ) | -- | 16.52 | 6.74 | |
| Price to Cash Flow (TTM) | -- | 21.65 | 24.12 | |
| % Owned Institutions | -- | 4.69 | 1.65 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.05 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 1.26 | 1.37 | |
| Dividend 5 Year Growth Rate | -- | 16.18 | 4.71 | |
| Payout Ratio(TTM) | -- | 30.83 | 39.59 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -64.35 | 8.64 | 13.45 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -42.76 | 2.20 | 8.04 | |
| Sales - 5 Yr. Growth Rate | -5.00 | 8.62 | 10.84 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -54.02 | 59.83 | 48.19 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -28.03 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 19.53 | 10.46 | |
| Capital Spending - 5 Yr. Growth Rate | 36.90 | 7.98 | 14.68 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 0.14 | 2.44 | 2.18 |
| Current Ratio (MRQ) | 0.22 | 3.17 | 2.98 |
| LT Debt to Equity (MRQ) | -- | 29.40 | 11.35 |
| Total Debt to Equity (MRQ) | -- | 36.33 | 16.04 |
| Interest Coverage (TTM) | -149.72 | 15.67 | 28.45 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 17.36 | 58.68 | 52.36 | |
| Gross Margin - 5 Yr. Avg. | 50.95 | 58.15 | 50.39 | |
| EBITD Margin (TTM) | -153.74 | -- | -- | |
| EBITD - 5 Yr. Avg | -110.22 | 22.91 | 12.41 | |
| Operating Margin (TTM) | -244.46 | 17.63 | 5.62 | |
| Operating Margin - 5 Yr. Avg. | -131.86 | 15.80 | 8.00 | |
| Pre-Tax Margin (TTM) | -244.96 | 17.42 | 4.64 | |
| Pre-Tax Margin - 5 Yr. Avg. | -125.55 | 16.06 | 8.28 | |
| Net Profit Margin (TTM) | -244.96 | 13.30 | 1.37 | |
| Net Profit Margin - 5 Yr. Avg. | -125.55 | 11.21 | 4.69 | |
| Effective Tax Rate (TTM) | -- | 23.20 | 22.13 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 28.88 | 22.58 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 53,082 | 28,867,337 | 819,624,671 | |
| Net Income/Employee (TTM) | -130,029 | 3,199,994 | 92,776,869 | |
| Receivable Turnover (TTM) | 10.46 | 5.07 | 5.82 | |
| Inventory Turnover (TTM) | 3.58 | 3.32 | 3.42 | |
| Asset Turnover (TTM) | 0.80 | 0.79 | 0.90 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -195.99 | 10.43 | 10.65 | |
| Return on Assets - 5 Yr. Avg. | -60.29 | 8.95 | 11.77 | |
| Return on Investment (TTM) | -- | 13.70 | 13.82 | |
| Return on Investment - 5 Yr. Avg. | -76.85 | 11.59 | 15.32 | |
| Return on Equity (TTM) | -- | 16.39 | 15.24 | |
| Return on Equity - 5 Yr. Avg. | -79.39 | 13.89 | 16.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -42.76 | -18.76 | -5.00 |
| EPS (TTM) % | -28.09 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Antares Pharma Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 23.61 | 12.66 | 90 | 52 |
| 13 Week | 7.37 | -0.08 | 65 | 73 |
| 26 Week | 2.42 | 16.39 | 42 | 63 |
| 52 Week | 38.61 | 55.81 | 76 | 42 |
| YTD | 2.36 | -4.98 | 34 | 41 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.